Concepedia

Adam Langenbucher

AL

18

Publications

2.4K

Citations

18

H-Index

2018

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Broad Institute

University of California, Irvine

Howard Hughes Medical Institute

Adam Langenbucher is an author at Harvard University specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer ResearchOncologyLung CancerPharmacologyCancer BiologyCancer TherapyCancer Genetics

Publications per year

2018–2023

18

Publications

18

Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer

Matteo Ligorio, Srinjoy Sil, Jose Malagon-Lopez et al. · Cell · 2019 · 519 citations · Full text

Pancreatic Cancer, Biological Microenvironments, Medicine +3

Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features

Rémi Buisson, Adam Langenbucher, Danae Bowen et al. · Science · 2019 · 315 citations · Full text

Engineering, Genetics, Tumor Heterogeneity +18

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer

Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 298 citations · Full text

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

Leila Dardaei, Hui Qin Wang, Manrose Singh et al. · Nature Medicine · 2018 · 198 citations · Full text

Alk Inhibitors, Medicine, Pharmacology +8

MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 188 citations · Full text

Rows per page

1–5 of 18